logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Cisplatin/gemcitabine/pembrolizumabLack of efficacy and asymptomatic hypothyroidism: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2022年 / 1930卷 / 1期
关键词:
D O I:
10.1007/s40278-022-26456-4
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:193 / 193
相关论文
共 50 条
  • [41] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1909 (1) : 456 - 456
  • [42] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1924 (1) : 365 - 365
  • [43] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2023, 1939 (1) : 378 - 378
  • [44] PembrolizumabLack of efficacy : case report
    Reactions Weekly, 2023, 1951 (1) : 276 - 276
  • [45] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2025, 2057 (1) : 305 - 305
  • [46] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2024, 2034 (1) : 319 - 319
  • [47] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2023, 1944 (1) : 474 - 474
  • [48] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2023, 1975 (1) : 307 - 307
  • [49] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2023, 1948 (1) : 358 - 358
  • [50] PembrolizumabLack of efficacy: case report
    Reactions Weekly, 2024, 2022 (1) : 232 - 232
← 12345 →